Lyra Therapeutics approves 1-for-50 reverse stock split, effective May 27

Lyra Therapeutics, Inc.

Stockholders approved reverse-split authority at 1-for-10 to 1-for-50 range; Board set final ratio at 1-for-50.
Reverse split effective 5:00 p.m. ET May 27, 2025; split-adjusted trading starts May 28 under symbol LYRA.
No fractional shares issued; holders receive cash payment based on May 27 closing price.
CUSIP changes to 55234L204 after split.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.